Respiratory illnesses can present with similar symptoms, making them difficult to diagnose. Accurate and timely diagnosis is critical to provide the best care for patients.
Due to the COVID-19 pandemic, respiratory infections have become more sporadic. With the absence and reemergence of pathogens, it is difficult to predict when the next surge of COVID-19, flu, or respiratory syncytial virus (RSV) will occur. Many of the symptoms overlap in nature, and thus, it is critical to differentiate with a diagnostic.
Stay up to date on Roche Diagnostics' efforts regarding the COVID-19 pandemic.
While COVID, flu and RSV are the most commonly discussed, a wide variety of viruses and bacteria can cause respiratory symptoms and illnesses. Though it's not important to test for everything, it can be important for patients with other conditions. Most physician practices, hospitals and laboratories provide a wide range of testing solutions based on the need.
SARS-CoV-2, unlike other respiratory viruses, is different; there's no true COVID season. The pandemic has changed our lives, and in the U.S., over 95 million cases have been reported as of September 2022.
Though it's hard to tell exactly what will happen with COVID-19 being prepared can help you make the best choices to protect yourself.
Influenza is commonly a seasonal virus that infects the nose, throat and lungs. The contagious virus has two main types: A or B. Within the U.S., around 9 million to 41 million people contract the flu.
As the flu can impact your daily routine and life, having access to quick and efficient testing is crucial to ensure optimal treatment.
RSV is a respiratory virus that typically causes mild, cold-like symptoms. While anyone can be infected with RSV, young children and older adults are more vulnerable. Each year around 58,000 children under age 5 are hospitalized in the U.S. due to RSV infection.
Understanding when to test can help you ensure your safety and that of the people in your life.
Having a precise and timely diagnosis during surge times is pivotal to curbing transmission, contributing to clinical decision-making and supporting healthcare systems. With nearly 30 years in respiratory research, we focus on improving outcomes for patients with respiratory diseases and partnering with laboratories across the country.